Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Immunogenicity As with all therapeutic proteins and peptides, there is a potential for the development of an immune response in the form of anti-drug antibodies (ADAs)
Our projected 24% reduction in cardiovascular events in persons with overweight or obesity but without cardiovascular disease from tirzepatide compares favorably to the well-publicized SELECT trial published last year involving another weight-loss medication Wegovy (semaglutide 2.4 milligram), which was studied in persons with cardiovascular disease and showed a 20% reduction in future cardiovascular events, said Wong, who also previously published a similar analysis of semaglutide estimating an 18% risk reduction in persons without cardiovascular disease
Early intervention can help identify the underlying cause and ensure appropriate management
Aversion therapy, which involves using unpleasant stimuli to discourage certain behaviors, is not covered due to concerns about its effectiveness and ethical considerations in the treatment of addiction
**Based on a placebo-controlled, crossover clinical study of 19 participants who took identical test meals, once with Flatter Me and once with a placebo
Retrieved from Hameed, A
